Key Lung Journal Articles - Metastatic

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2
R Lilenbaum, R Axelrod, S Thomas, A Dowlati, L Seigel, D Albert, K Witt, & D Botkin
JCO. Feb 20 2008; 26(6):863-869
Article review by Dr C Butts | Journal | Pubmed

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599
SS Ramalingam, SE Dahlberg, CJ Langer, R Gray, CP Belani, JR Brahmer, AB Sandler, JH Schiller, & DH Johnson
JCO. Jan 1 2008; 26(1):60-65
Article review by Dr C Butts | Journal | Pubmed

Phase II Clinical Trial of Chemotherapy-Naïve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
DM Jackman, BY Yeap, NI Lindeman, P Fidias, MS Rabin, J Temel, AT Skarin, M Meyerson, AJ Holmes, AM Borras, B Freidlin, PA Ostler, J Lucca, TJ Lynch, BE Johnson, & PA Jänne
JCO. Mar 1 2007; 25(7):760-6
Article review by Dr C Butts | Journal | Pubmed

Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer
LV Sequist, DW Bell, TJ Lynch, & DA Haber
JCO. Feb 10 2007; 25(5):587-95
Article review by Dr C Butts | Journal | Pubmed